Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance.
- NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_assertion description "[These findings mechanistically implicate HDAC7 and Nur77 in sensitizing human CTCL cells to panobinostat as well as suggest that cotreatment with an anti-Bcl-2 agent would augment the anti-CTCL activity of panobinostat.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance.
- NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_assertion evidence source_evidence_literature NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance.
- NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_assertion SIO_000772 19074726 NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance.
- NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_assertion wasDerivedFrom befree-20150227 NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance.
- NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_assertion wasGeneratedBy ECO_0000203 NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP460933.RAeG_EG2OTRAFKW3v5VtPaK2q4t6jDTvUgGHqOGEoSDjI130_provenance.